Temporal shifts in diagnostic testing for cardiac amyloidosis across U.S. health systems. [PDF]
Motairek I +7 more
europepmc +1 more source
Correction to 'Pharmacological Interventions for Hereditary Transthyretin-Related Amyloidosis With Polyneuropathy: Systematic Review and Network Meta-Analysis'. [PDF]
europepmc +1 more source
Transthyretin Cardiac Amyloidosis in Women: Underdiagnosis, Sex-Specific Phenotypic Expression and Therapeutic Response. [PDF]
Barocelli F +13 more
europepmc +1 more source
First clinical experience with the Transthyretin Amyloidosis-Quality of Life questionnaire (ATTR-QoL): associations with clinical characteristics and established patient-reported outcomes. [PDF]
Bampatsias D +11 more
europepmc +1 more source
Case Report: Five-year follow-up of leptomeningeal transthyretin amyloidosis (Ala45Thr) with CNS involvement under tolcapone therapy. [PDF]
Giedraitienė N +2 more
europepmc +1 more source
Transthyretin Cardiac Amyloidosis in an Older Athlete. [PDF]
O'Brien D, Reiss RA.
europepmc +1 more source
Disease modifying treatment of hereditary transthyretin amyloidosis with polyneuropathy in Germany - expert consensus of the German society of amyloid diseases (DGAK) and the German neurological society (DGN). [PDF]
Weiler M +14 more
europepmc +1 more source
Synovial Biopsy as a Diagnostic Clue for Transthyretin Amyloidosis With the Rare Tyr98Phe Variant Presenting Predominantly With Severe Musculoskeletal Manifestations. [PDF]
Milani R +4 more
europepmc +1 more source
Therapy of Transthyretin Cardiomyopathy
openaire +2 more sources

